Use of Anabolic steroids in malnourished pulmonary tuberculosis patients.

D. Chawla (karachi, Pakistan)

Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Session: Paediatric TB: MDRTB (II)
Session type: Thematic Poster
Number: 2766
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Chawla (karachi, Pakistan). Use of Anabolic steroids in malnourished pulmonary tuberculosis patients.. 2766

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of antituberculosis chemotherapy on thyroid hormones in active pulmonary tuberculosis patients
Source: Eur Respir J 2001; 18: Suppl. 33, 306s
Year: 2001

Use of surfactant-BL (S-BL) in complex treatment of pulmonary TB patients
Source: Eur Respir J 2003; 22: Suppl. 45, 521s
Year: 2003

Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Nutritional deficiency in patients with pulmonary tuberculosis
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021


Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Safety of corticosteroid therapy in patients with pulmonary sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017


Side-effect in the treatment of pulmonary tuberculosis by first-line drugs
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Aspects of diagnosis and treatment in pulmonary tuberculosis in children
Source: Eur Respir J 2002; 20: Suppl. 38, 168s
Year: 2002

Pulmonary tuberculosis in elderly patients
Source: Eur Respir J 2007; 30: Suppl. 51, 418s
Year: 2007

Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 15s
Year: 2002

Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Rationale for use of inhaled steroids in children with bronchiectasis
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019

Statin with standard antituberculosis regimen and mortality in hospitalized pulmonary tuberculosis
Source: International Congress 2019 – Tuberculosis: treatment and management
Year: 2019


Corticosteroids as adjunctive therapy in tuberculosis pneumonia with ART
Source: Breathe 2008; 5: 274
Year: 2009

Effect of bronchodilator therapy on the quality of life of pulmonary TB patients
Source: Eur Respir J 2002; 20: Suppl. 38, 442s
Year: 2002

Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with asthma
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Anabolic steroids in acute and chronic disease
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=163
Year: 2003

Effects of complex treatment with izofon of a pulmonary tuberculosis in children
Source: Eur Respir J 2004; 24: Suppl. 48, 652s
Year: 2004

Changes in the quality of life of pulmonary TB patients depending on the severity of bronchial obstruction when using standard antituberculosis therapy and inhaled bronchodilator therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 21s
Year: 2003